Order Article Reprints

Rossi J-F, Bonnet E, Castelli C, Velensek M, Wisniewski E, Heraud S, Boustany R, David C, Dinet J, Sicard R, et al. Clinical and Serological Follow-Up of 216 Patients with Hematological Malignancies after Vaccination with Pfizer-BioNT162b2 mRNA COVID-19 in a Real-World Study. Vaccines. 2023; 11(3):493. https://doi.org/10.3390/vaccines11030493

Rossi, Jean-François, Emmanuel Bonnet, Christel Castelli, Marion Velensek, Emma Wisniewski, Sophie Heraud, Rania Boustany, Céleste David, Jérôme Dinet, Roland Sicard, and et al. 2023. "Clinical and Serological Follow-Up of 216 Patients with Hematological Malignancies after Vaccination with Pfizer-BioNT162b2 mRNA COVID-19 in a Real-World Study" Vaccines 11, no. 3: 493. https://doi.org/10.3390/vaccines11030493

Rossi, J.-F., Bonnet, E., Castelli, C., Velensek, M., Wisniewski, E., Heraud, S., Boustany, R., David, C., Dinet, J., Sicard, R., Daures, J.-P., Bonifacy, M., Mousset, L., & Goffart, E. (2023). Clinical and Serological Follow-Up of 216 Patients with Hematological Malignancies after Vaccination with Pfizer-BioNT162b2 mRNA COVID-19 in a Real-World Study. Vaccines, 11(3), 493. https://doi.org/10.3390/vaccines11030493